Hofseth Biocare ASA: Disclosure of large shareholding

16 October 2020 - 13:44

Reference is made to the stock exchange notice from Hofseth BioCare ASA dated 16 October 2020 regarding the private placement of NOK 200m (the "Private Placement").

As a consequence of the Private Placement the shareholding of funds managed by Bonafide (Bonafide Global Fish Fund, Bonafide Best Catches I, Deep Blue Ventures I, and Deep Blue Ventures III) falls below 20 % of the total shares outstanding in Hofseth BioCare ASA following the Private Placement. Bonafide funds controls a total of 69,302,732 shares in Hofseth BioCare ASA corresponding to approx. 19.53 % of total shares outstanding after the Private Placement.

This information is subject to the disclosure requirements pursuant to sections 4-3 and 5-12 of the Norwegian Securities Trading Act.

Provided by: GlobeNewswire
Oslo Axess (Norway)
Hofseth BioCare ASA
Hofseth BioCare's key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology, HBC is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. HBC is thus contributing to efficient use of marine resources...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date